Zibotentan in systemic sclerosis-associated chronic kidney disease: a phase II randomised placebo-controlled trial

被引：0
作者：
Edward P. Stern
Lauren V. Host
Ivy Wanjiku
K. Jane Escott
Peter S. Gilmour
Rachel Ochiel
Robert Unwin
Aine Burns
Voon H. Ong
Helen Cadiou
Aidan G. O’Keeffe
Christopher P. Denton
机构：
[1] University College London,Division of Medicine
[2] Royal Free Campus,Emerging Innovations Unit
[3] BioPharmaceuticals R&D,Early Clinical Development, Cardiovascular, Renal & Metabolism
[4] AstraZeneca,Joint Research Office
[5] BioPharmaceuticals R&D,School of Mathematical Sciences
[6] AstraZeneca,undefined
[7] University College London,undefined
[8] University of Nottingham,undefined
[9] UCL Centre for Rheumatology and Connective Tissue Diseases,undefined
来源：
Arthritis Research & Therapy | / 24卷
关键词：
Scleroderma; Renal crisis; Chronic kidney disease; Endothelin; Zibotentan;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 324 条
[41]  
Kötter I(undefined)undefined undefined undefined undefined-undefined
[42]  
Simsek I(undefined)undefined undefined undefined undefined-undefined
[43]  
de la Pena Lefebvre PG(undefined)undefined undefined undefined undefined-undefined
[44]  
Hachulla E(undefined)undefined undefined undefined undefined-undefined
[45]  
Seibold JR(undefined)undefined undefined undefined undefined-undefined
[46]  
Rednic S(undefined)undefined undefined undefined undefined-undefined
[47]  
Stork J(undefined)undefined undefined undefined undefined-undefined
[48]  
Morovic-Vergles J(undefined)undefined undefined undefined undefined-undefined
[49]  
Walker UA(undefined)undefined undefined undefined undefined-undefined
[50]  
Penn H(undefined)undefined undefined undefined undefined-undefined
12345678910